Litigation

Recent Posts

Amylin Sues Eli Lilly Over Diabetes Drug Development Deal
Posted on 17 May 2011 by LexisNexis Litigation Resource Community Staff

INDIANAPOLIS - (AP) Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim... Read More

Eli Lilly Loses Patent Lawsuit For Drug Strattera
Posted on 13 Aug 2010 by LexisNexis Litigation Resource Community Staff

INDIANAPOLIS - (AP) Eli Lilly & Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera. The U.S. District Court for the District of New Jersey ruled against the... Read More

2nd Circuit Reject Overpromotion Exception To Learned Intermediary In Zyprexa Case
Posted on 16 Jul 2010 by Tom Moylan

NEW YORK - (Mealey's) A Second Circuit U.S. Court of Appeals panel on July 16 ruled that a Zyprexa multidistrict litigation plaintiff failed to show that alleged overpromotion of the atypical antipsychotic drug by manufacturer Eli Lilly and Co. misled... Read More

2nd Circuit Affirms Injunction Against Lawyer Who Disclosed Zyprexa MDL Documents
Posted on 12 Aug 2010 by Tom Moylan

NEW YORK - (Mealey's) The Zyprexa multidistrict litigation court properly enjoined an Alaska attorney and mental health advocate from obtaining and disseminating confidential discovery documents produced by Eli Lilly and Co., a panel of the Second... Read More

AstraZeneca Settles Nearly 4,000 Seroquel Injury Claims; Terms Confidential
Posted on 30 Jul 2010 by Tom Moylan

LONDON - (Mealey's) AstraZeneca PLC said July 29 that it has agreed in principle to settle with nearly 4,000 Seroquel product liability plaintiffs. The company said settlement terms are confidential. In notes to its second-quarter financial... Read More